Company: STAA
Filing Date: 2025-10-28
Form Type: DEFA14A
Source: 0001193125-25-252202
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-10-28
Form: DEFA14A
Chunk 1
---
 other materials to such stockholders in advance of the meeting date.

We recognize that there has been a lot of noise around STAAR over the last several months, and we could not be more proud of the resilience this team has
shown. You have continued to execute with a relentless commitment to our priorities and a fierce dedication to supporting the surgeons and patients around the world who rely on STAAR.

Nothing is changing for STAAR with today’s announcement, and our original merger timeline remains intact. Prior to the closing of the merger, we will
continue to operate business as usual. The best way for you to help is by remaining focused on your responsibilities to advance the important work underway across the Company to expand the reach of EVO ICL to provide visual freedom for those in
need.

On behalf of the STAAR Board of Directors and management team, thank you for your continued dedication to STAAR and our mission.

Sincerely,

Stephen C. Farrell

Chief Executive Officer

Additional Information About the Merger and Where to Find It

This communication relates to the proposed transaction involving STAAR. In connection with the proposed transaction, STAAR has filed relevant materials with
the U.S. Securities and Exchange Commission (the “SEC”), including STAAR’s definitive proxy statement on Schedule 14A (the “Proxy Statement”), on September 16, 2025. The Proxy Statement was first sent to STAAR
stockholders on September 16, 2025. This communication is not a substitute for the Proxy Statement or any other document that STAAR may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY
VOTING DECISION, STOCKHOLDERS OF STAAR ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY
BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC’s website, www.sec.gov, or by
visiting STAAR’s investor relations website, https://investors.staar.com.

No Offer or Solicitation

This communication is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the
solicitation of an